PMID: 69 CiaffiJMitselmanDMancarellaLBrusiVLisiLRuscittiPet al
Study authors are generally careful to frame these effects as most pronounced within controlled research protocols that include structured training and caloric variables the literature does not describe IGF-1 LR3 as a standalone driver of fat loss independent of those conditions
The more accurate label is libido-pathway peptide, not testosterone booster
Researches show that aging, chronic degenerative diseases like Parkinsons, Alzheimers disease are strongly associated with a reduced level of glutathione in brain cells
Given that retatrutide is not a licensed medicine in the UK, there is no formal NHS prescribing pathway for it at present
At Optimal Health Medical, conversations about peptide therapy are approached through medical evaluation, symptom review, medication and supplement review, lab-informed decision-making when appropriate, realistic expectations, safety education, and follow-up